Pacific Biosciences of Ca... (PACB)
NASDAQ: PACB
· Real-Time Price · USD
1.23
0.00 (0.00%)
At close: Sep 17, 2025, 3:59 PM
1.29
4.88%
Pre-market: Sep 18, 2025, 06:02 AM EDT
0.00% (1D)
| Bid | 1.21 |
| Market Cap | 369.46M |
| Revenue (ttm) | 156.11M |
| Net Income (ttm) | -526.36M |
| EPS (ttm) | -2.23 |
| PE Ratio (ttm) | -0.55 |
| Forward PE | -2.41 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 1.25 |
| Volume | 7,375,195 |
| Avg. Volume (20D) | 7,829,217 |
| Open | 1.24 |
| Previous Close | 1.23 |
| Day's Range | 1.22 - 1.32 |
| 52-Week Range | 0.85 - 2.72 |
| Beta | 1.87 |
| Ex-Dividend Date | n/a |
About PACB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PACB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PACB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsPacific Biosciences of California Inc. is scheduled to release its earnings on
Nov 6, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+7.14%
Pacific Biosciences shares are trading higher afte...
Unlock content with
Pro Subscription
1 month ago
-8.7%
PACB stock has given up its prior gain. Pacific Biosciences shares were trading higher after the company reported better-than-expected Q2 financial results.
1 month ago · seekingalpha.com
Pacific Biosciences of California, Inc. (PACB) Q2 2025 Earnings Call TranscriptPacific Biosciences of California, Inc. (NASDAQ:PACB ) Q2 2025 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Christian O. Henry - President, CEO & Director James R.
1 month ago · fool.com
PACB Sales Up 11%PACB Sales Up 11%
